Diabetes Medication May Help Combat Triple-Negative Breast Cancer

Early research finds evidence that diabetes drug along with another medication may help women with virulent cancer.

Triple-negative breast cancers (TNBCs) account for roughly 10 to 15 percent of all breast cancers. They disproportionately affect African American and Hispanic women, young women, and women with mutations on the BRCA1 gene.